VerticalNews VerticalNews
VerticalNews VerticalNews VerticalNews VerticalNews     VerticalNews VerticalNews

VerticalNews
Government
Technology
Science
International
Business
Ecology & Environment
Entertainment
Education
VerticalNews
VerticalNews
VerticalNews
VerticalNews

Food Business Week

Welcome to VerticalNews!

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Immunosorbent Techniques



AquaStar Holdings, Inc.'s Subsidiary Signs Multi-Million Dollar Venture Accelerator Agreement To Develop Portable Healthcare Diagnostic Technology



April 28th, 2011

AquaStar Holdings, Inc. (Pink Sheets: RPPR) is pleased to announce that the Company's wholly-owned subsidiary, SUTIMCo, has signed a Venture Acceleration Agreement with Capwave Sensor, Inc., valued at $2,790,000. Capwave is the maker of a revolutionary portable Enzyme-Linked ImmunoSorbent Assay (ELISA) test platform. According to the terms of the Agreement, SUTIMCo will assist Capwave with development and commercialization of its technology for a period of three years at $77,500 per month.

Developed at the State University of New York Binghamton by Professor Omowunmi Sadik, Capwave is a rapid, sensitive, and portable Enzyme-Linked ImmunoSorbent Assay (ELISA) platform for...

Click here for more articles from Immunosorbent Techniques


Source: Food Business Week (2011-04-28)

VerticalNews
VerticalNews

VerticalNews
SSL VerticalNews